Oryzon Genomics S.A. Stock
Stocks
ORY
ES0167733015
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
BME
11:35:17 2026-10-01 EDT
|
After hours 15:59:59 | |||
| 2.754 EUR | -0.86% |
|
2.759 | +0.18% |
| 08-31 | The IBEX starts the week with doubts as Iran tensions escalate, but logs five straight months of gains | RE |
| 08-31 | Spanish stocks - Factors to watch on Aug 31 | RE |
| Market Cap | 226M 254M 211M 192M 362M 24.47B 367M 2.55B 989M 12.46B 954M 933M 40.03B | P/E 2026 * |
-29.9x | P/E 2027 * | 306x |
|---|---|---|---|---|---|
| Enterprise Value | 230M 258M 215M 196M 368M 24.88B 373M 2.6B 1.01B 12.67B 970M 949M 40.7B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
76.21% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
BME
| ORY | Delayed | |
OTC Markets
| ORYZF | Delayed | |
|
CBOE
| ORYe | Real-time | |
|
Tradegate
| ORN | Real-time | |
|
CBOE
| 0RDB | Real-time | |
|
Deutsche Boerse AG
| ORN | Delayed | |
|
Börse Stuttgart
| ORN | Delayed | |
|
Boerse Muenchen
| ORN | Real-time |
| 1 day | -0.68% | ||
| 1 week | +0.81% | ||
| Current month | -0.86% | ||
| 1 month | -1.57% | ||
| 3 months | -10.93% | ||
| 6 months | -0.22% | ||
| Current year | -11.45% |
| 1 week | 2.71 |  | 2.81 |
| 1 month | 2.69 | | 2.85 |
| Current year | 2.6 | | 3.4 |
| 1 year | 2.6 | | 4.02 |
| 3 years | 1.4 | | 4.02 |
| 5 years | 1.4 | | 4.02 |
| 10 years | 1.4 | | 5.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2000-06-01 | |
| Director of Finance/CFO | - | 2011-04-30 | |
Ana Limon
CTO | Chief Tech/Sci/R&D Officer | - | 2022-01-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2000-06-01 | |
| Director/Board Member | - | 2020-05-10 | |
| Director/Board Member | - | 2025-02-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/12/24 | Exercice | 15,000 | 0.0242% | |||
| 2/8/24 | Exercice | Chief Technology Officer | 10,000 | 0.0161% | ||
| 12/30/20 | Sell | Founder | 250,000 | 0.4711% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.86% | +0.81% | -7.27% | +34.67% | 259M | |
| +4.16% | -0.36% | +49.37% | +94.17% | 74.46B | |
| -0.61% | +0.69% | +36.36% | +82.72% | 60.14B | |
| -2.54% | -0.21% | +6.34% | +31.72% | 48.15B | |
| -3.02% | -5.20% | +27.94% | +34.47% | 44.25B | |
| +0.31% | +3.02% | +348.95% | +686.74% | 43.99B | |
| -1.96% | -0.33% | +7.04% | +100.99% | 41.61B | |
| +3.32% | +3.49% | +11.18% | +51.23% | 29.97B | |
| +4.77% | +6.16% | +36.77% | +22.78% | 29.31B | |
| -4.86% | -10.66% | -26.27% | +328.03% | 24.93B | |
| Average | -0.10% | +1.94% | +49.04% | +146.75% | 39.71B | |
| Weighted average by Cap. | +0.18% | +1.83% | +59.95% | +150.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -8.63M -9.72M -8.07M -7.36M -13.85M -936M -14.04M -97.68M -37.81M -477M -36.5M -35.7M -1.53B | -4.37M -4.93M -4.09M -3.73M -7.02M -474M -7.11M -49.49M -19.16M -242M -18.49M -18.09M -776M |
| Net Debt | 3.8M 4.27M 3.55M 3.23M 6.09M 411M 6.17M 42.93M 16.62M 210M 16.04M 15.69M 673M | 25.01M 28.16M 23.39M 21.31M 40.13M 2.71B 40.68M 283M 110M 1.38B 106M 103M 4.43B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-01 | €2.754 | -0.86% | 81,838 |
| 26-09-30 | €2.778 | +2.51% | 190,927 |
| 26-09-29 | €2.710 | -1.45% | 164,753 |
| 26-09-28 | €2.750 | +0.66% | 216,114 |
| 26-09-25 | €2.732 | +0.07% | 91,297 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ORY Stock
Select your edition
All financial news and data tailored to specific country editions
